High blood pressure, blood sugar and inflammation are three risk factors that increase the chance of developing heart disease and other cardiovascular disease, according to the Centers for Disease Control and Prevention
In fact, estrogen has been shown to enhance both satiety and metabolic effects of prescription GLP-1 drugs with observational studies having shown that women using both therapies achieved about 35% more weight lost than those on GLP-1 only
Special considerations for different GLP-1 delivery methods Not all GLP-1 medications come as traditional injections, and the delivery method affects site selection considerations
However, people with a personal or family history of Medullary Thyroid Cancer or MEN 2 syndrome are advised to avoid these drugs as a precaution
Simonson SG, Welty-Wolf KE, Huang YC, Taylor DE, Kantrow SP, Carraway MS, et al